|
- Treatment and Recovery | National Institute on Drug Abuse
Certain treatment medications and devices reduce these symptoms, which makes it easier to stop the drug use Staying in treatment Some treatment medications and mobile applications are used to help the brain adapt gradually to the absence of the drug These treatments act slowly to help prevent drug cravings and have a calming effect on body
- Treatment - National Institute on Drug Abuse (NIDA)
For example, treatment with methadone, buprenorphine, or naltrexone is standard of care for opioid use disorder The medication lofexidine is approved for treatment of opioid withdrawal symptoms Medications are also available for the treatment of alcohol use disorder and to help people quit smoking Depending on the type of medication, it may:
- principles of drug addiction treatment - National Institute on Drug . . .
3 Treatment needs to be readily available Because drug-addicted individuals may be uncertain about entering treatment, taking advantage of available services the moment people are ready for treatment is critical Potential patients can be lost if treatment is not immediately available or readily accessible As with
- Principles of Adolescent Substance Use Disorder Treatment: A Research . . .
Disorder Treatment: A Research-Based Guide Published in 2014, this report offered health professionals and other stakeholders information on principles of effective drug addiction treatment, answers to frequently asked questions, an overview of the drug addiction treatment landscape in the United States, and an outline of evidence-based treatment
- Advancing reduction of drug use as an endpoint in addiction treatment . . .
It can pose a barrier to seeking and entering treatment and perpetuate stigma and shame at treatment setbacks By the same token, reduction of substance use has important public health benefits as well as clinical benefits for patients, and recognition of this could greatly advance medication development for treatment of addiction and its symptoms
- Ketamine | National Institute on Drug Abuse (NIDA)
Ketamine is FDA-approved for use as an anesthetic in humans and animals A drug made from ketamine, called esketamine, is FDA-approved for treatment-resistant depression Ketamine has also been illegally manufactured for decades as a recreational drug Ketamine can cause strong mood and mind effects People who take ketamine may experience
- What are treatments for tobacco dependence? | National Institute on . . .
The prevalence of tobacco use and dependence among adolescents—as well as the neurobiological impact and medical consequences of nicotine exposure—suggest that pediatric primary care settings should deliver tobacco cessation treatments to both youth and parents who use tobacco 169 Current clinical guidance does not recommend medications for adolescent tobacco cessation because of a lack
- Addiction Treatment - National Institute on Drug Abuse (NIDA)
In 2021, approximately 43 7 million people aged 12 or older (15 6% of the population) needed substance use treatment in the past year However, only 6 8% of them received substance use treatment at a specialty facility (2021 DT 5 39B) *1 Review these research-based guides for helpful information on addiction treatment
|
|
|